OVERVIEW OF ANTIMICROBIAL STEWARDSHIP

OVERVIEW OF
ANTIMICROBIAL STEWARDSHIP
DR TANVEER REHMAN
SCIENTIST – B (MEDICAL)
PUBLIC HEALTH DIVISION
25/09/2023 AMS Dr Tanveer Rehman RMRCBB 2
Background
• Global Action Plan on Antimicrobial Resistance (AMR)
• Overuse and misuse of antimicrobials as a main driver for development of AMR
• Optimize the use of antimicrobial medicines in human and animal health
• Practical guidance on how to implement antimicrobial stewardship (AMS)
programmes in the human health sector at health-care facility
• Improve patient outcomes, reduce AMR and health-care-associated infections,
and save health-care costs amongst others
25/09/2023 AMS Dr Tanveer Rehman RMRCBB 3
Antimicrobial stewardship
• Careful and responsible management of something entrusted to one’s care
• Applied in the health-care setting as a tool for optimizing antimicrobial use
• One of three “pillars” of an integrated approach to health system strengthening
• Infection prevention and control (IPC) and medicine and patient safety
• WHO essential medicines list (EML) AWaRe classification
• Promotes equitable and quality health care towards the goal of achieving
universal health coverage (UHC)
25/09/2023 AMS Dr Tanveer Rehman RMRCBB 4
‘Access’ Group – WHO ‘AWaRe’
25/09/2023 AMS Dr Tanveer Rehman RMRCBB 5
‘WAtch’ Group – WHO ‘AWaRe’
25/09/2023 AMS Dr Tanveer Rehman RMRCBB 6
‘REserve’ Group – WHO ‘AWaRe’
25/09/2023 AMS Dr Tanveer Rehman RMRCBB 7
25/09/2023 AMS Dr Tanveer Rehman RMRCBB 8
Aim of AMS
• Optimize the use of antibiotics
• Promote behaviour change in antibiotic prescribing and dispensing practices
• Improve quality of care and patient outcomes
• Save on unnecessary health-care costs
• Reduce further emergence, selection and spread of AMR
• Prolong the lifespan of existing antibiotics
• Build the best-practices capacity of health-care professionals
25/09/2023 AMS Dr Tanveer Rehman RMRCBB 9
25/09/2023 AMS Dr Tanveer Rehman RMRCBB 10
25/09/2023 AMS Dr Tanveer Rehman RMRCBB 11
Antimicrobial prescribing facts
• 30% of all hospitalised in-patient at any given time receive antibiotics
• About 50% of antimicrobial use has been found to be inappropriate
• Up to 30% of all surgical prophylaxis is inappropriate
• URTI – reason for the 75% of the antibiotic prescriptions each year; in most
cases of URTIs, antibiotic confers little or no benefit
• 10-30% of antimicrobial cost can be saved by AMS
• Globally, dentists were reported to prescribe up to 11.3 % of all antibiotics.
25/09/2023 AMS Dr Tanveer Rehman RMRCBB 12
25/09/2023 AMS Dr Tanveer Rehman RMRCBB 13
Prospective (real-time) audit with feedback
• Prospective audit with feedback (e.g. on ward rounds) involves the assessment
of antibiotic therapy by AMS team, who make recommendations to prescribers
in real time when therapy is considered suboptimal.
• It may be performed alongside clinical personnel on ward rounds, providing
oral recommendations for changes in antibiotic treatment in real time.
• Alternatively, AMS team may perform ward rounds on their own, providing
written recommendations for changes in antibiotic treatment
25/09/2023 AMS Dr Tanveer Rehman RMRCBB 14
Formulary restriction/preauthorization
• Use of restricted antibiotics may be limited to certain indications, prescribers,
services, patient populations or a combination of these.
• Selection of restricted antibiotics is done by facility authorities, the AMS team
and heads of units based on spectrum, cost or toxicities.
• Antibiotics are restricted before use; ensures expert approval before initiation
• Practical approach that allows attending physician to use the drug pending
approval by physician or AMS team after +/− 48 hours
25/09/2023 AMS Dr Tanveer Rehman RMRCBB 15
Didactic education
• Formal or informal teaching to engage prescribers in improving antibiotic
prescribing, dispensing and administration practices
• Clinical case discussions, classes, reminders, conference presentations, student
and house staff teaching sessions, provision of written guidelines,
informational pamphlets, posters or e-mail alert – STG/ updates
• Education alone, without incorporation of active intervention is only
marginally effective
25/09/2023 AMS Dr Tanveer Rehman RMRCBB 16
Streamlining/de-escalation
• All clinicians should perform a review of antibiotics 48 hours after prescription
• When microbiological results become available, antibiotic treatment should be
streamlined accordingly: choose the most active antibiotic(s) with least
toxicity, narrowest spectrum and lowest cost
• De-escalation is safe for sepsis and septic shock, and is associated with
decreased mortality
25/09/2023 AMS Dr Tanveer Rehman RMRCBB 17
25/09/2023 AMS Dr Tanveer Rehman RMRCBB 18
Outcome measures
• Outcome measures/indicators related to antimicrobial use
DDD or DOTS per 100(0) patient-days: Defined Daily Dose of an agent from
pharmacy dispensing or health-care facility purchasing data or Days of Therapy
from nursing chart administrative data (paper) in a period of time
• Outcome measures/ indicators related to patients and microbiology
In-hospital mortality, Length of stay, Readmission within 30 days after discharge
Clostridium difficile: Number of health-care-associated C. difficile infections
25/09/2023 AMS Dr Tanveer Rehman RMRCBB 19
Common areas for improving antibiotic prescribing
• Overprescribing: when not needed, e.g. fever without evidence of infection,
viral infections, malaria, asymptomatic urinary tract colonization
• Overly broad spectrum: More broad-spectrum antibiotics (WATCH and
RESERVE) are prescribed than are necessary (e.g. surgical prophylaxis)
• Unnecessary combination therapy, including certain FDC: Multiple antibiotics
are used, particularly with overlapping spectra and in combinations that have
not been shown to improve clinical outcomes.
25/09/2023 AMS Dr Tanveer Rehman RMRCBB 20
Common areas for improving antibiotic prescribing
• Wrong antibiotic choice: Wrong antibiotic(s) are prescribed for particular
indications/infections.
• Wrong dose: Over- or under dosing
• Wrong dose interval: Antibiotics are prescribed with the wrong dose interval
(too much time between doses).
• Wrong route: Antibiotics are prescribed by the wrong route (e.g. IV instead of
oral).
25/09/2023 AMS Dr Tanveer Rehman RMRCBB 21
What can the individual physicians do
• Obtain appropriate cultures before starting antibiotic
• Review antibiotic use after 48 – 72 hours : does it need to be continued?
• Stop antibiotic in patient with alternative non-infectious diagnosis
• Optimize dosing and duration of antibiotic therapy
• Avoid unnecessary use, especially in viral upper respiratory tract infections
25/09/2023 AMS Dr Tanveer Rehman RMRCBB 22
Health-care facility AMS team
• Implements day-to-day AMS activities like conducting regular ward rounds
• Undertakes audits or PPSs to assess the appropriateness of antibiotic prescription
• Monitors, analyses and interprets the quantity and types of antibiotic use at the
unit and/or facility-wide level
• Monitors antibiotic susceptibility and resistance rates for a range of key indicator
bacteria at the facility-wide level or uses the data from existing groups
• Facilitates education and training on AMS in the facility.
25/09/2023 AMS Dr Tanveer Rehman RMRCBB 23
Health-care facility AMS team
Option 1: >2 : physician, a pharmacist, a nurse with expertise in infections or IPC,
and in facilities with a microbiology laboratory, a microbiologist
Option 2: a physician and a nurse or pharmacist, with access to expert advice
Option 3: an AMS champion, e.g. a physician, nurse or pharmacist leading the
stewardship programme, with access to expert advice (e.g. secondary or small
facilities with limited resources).
• Frequency of meetings: Weekly to two times a month
25/09/2023 AMS Dr Tanveer Rehman RMRCBB 24
THANK YOU
25/09/2023 AMS Dr Tanveer Rehman RMRCBB 25
References
1. ICMR. Antimicrobial Stewardship Program Guideline
2. Antimicrobial stewardship programmes in health-care facilities in low-and middle-income
countries: a WHO practical toolkit
3. Vijay S, Ramasubramanian V, Bansal N, Ohri VC, Walia K. Hospital-based antimicrobial
stewardship, India. Bulletin of the World Health Organization. 2023
1 sur 25

Recommandé

Management of adverse drug reactions par
Management of adverse drug reactionsManagement of adverse drug reactions
Management of adverse drug reactionsReshmaManeDeshmukh
2.4K vues8 diapositives
Pharmacovigilance par
PharmacovigilancePharmacovigilance
PharmacovigilanceGaurav kumar
7.4K vues26 diapositives
Evidence based medicine par
Evidence based medicineEvidence based medicine
Evidence based medicineHesham Gaber
2.5K vues18 diapositives
Purchasing and inventory control in drug store par
Purchasing and inventory control in drug storePurchasing and inventory control in drug store
Purchasing and inventory control in drug storePriyanka Kalamkar
673 vues47 diapositives
Clinical laboratory test interpretation par
Clinical laboratory test interpretationClinical laboratory test interpretation
Clinical laboratory test interpretationSmita Jain
55.6K vues45 diapositives
Cassualty assesment of adr par
Cassualty assesment of adrCassualty assesment of adr
Cassualty assesment of adrmohamed abusalih
773 vues33 diapositives

Contenu connexe

Tendances

DRUG STORE MANAGEMENT AND INVENTORY CONTROL par
DRUG STORE MANAGEMENT AND INVENTORY CONTROLDRUG STORE MANAGEMENT AND INVENTORY CONTROL
DRUG STORE MANAGEMENT AND INVENTORY CONTROLDR.HARI SINGH GOUR
5K vues22 diapositives
Ten and tpn par
Ten and tpnTen and tpn
Ten and tpnArooj Attique
1.9K vues11 diapositives
lab manual cpm.pdf par
lab manual cpm.pdflab manual cpm.pdf
lab manual cpm.pdfSUMIT TIWARI
1.5K vues9 diapositives
Compounding in hospital.pptx par
Compounding in hospital.pptxCompounding in hospital.pptx
Compounding in hospital.pptxArchana Chavhan
2.2K vues18 diapositives
Vaccination and health risk due to vaccination- a perspective par
Vaccination and health risk due to vaccination- a perspectiveVaccination and health risk due to vaccination- a perspective
Vaccination and health risk due to vaccination- a perspectiveAbhradeep Majumder
1K vues18 diapositives
Patient compliance simi joju k. par
Patient compliance simi joju k.Patient compliance simi joju k.
Patient compliance simi joju k.simisheeja
1.2K vues18 diapositives

Tendances(20)

Vaccination and health risk due to vaccination- a perspective par Abhradeep Majumder
Vaccination and health risk due to vaccination- a perspectiveVaccination and health risk due to vaccination- a perspective
Vaccination and health risk due to vaccination- a perspective
Patient compliance simi joju k. par simisheeja
Patient compliance simi joju k.Patient compliance simi joju k.
Patient compliance simi joju k.
simisheeja1.2K vues
Different Types of Allergy Testing par DoctorDoctor
Different Types of Allergy TestingDifferent Types of Allergy Testing
Different Types of Allergy Testing
DoctorDoctor1.9K vues
Case report form and application par Irene Vadakkan
Case report  form  and  applicationCase report  form  and  application
Case report form and application
Irene Vadakkan7.3K vues
High alert medication par muhaini84
High alert medicationHigh alert medication
High alert medication
muhaini846.6K vues
trial and protocol design par Rohit K.
trial and protocol design trial and protocol design
trial and protocol design
Rohit K.997 vues
Home remedies and patient counselling tips for ANEMIA-By rxvichu-alwz4uh!! :) :) par RxVichuZ
Home remedies and patient counselling tips for ANEMIA-By rxvichu-alwz4uh!! :) :)Home remedies and patient counselling tips for ANEMIA-By rxvichu-alwz4uh!! :) :)
Home remedies and patient counselling tips for ANEMIA-By rxvichu-alwz4uh!! :) :)
RxVichuZ 8.8K vues
Medication Reconciliation Education par cshowers5608
Medication Reconciliation EducationMedication Reconciliation Education
Medication Reconciliation Education
cshowers56082.9K vues
Hospital Pharmacy And Its Organization -Ravinandan A P par Ravinandan A P
Hospital Pharmacy  And Its Organization -Ravinandan  A PHospital Pharmacy  And Its Organization -Ravinandan  A P
Hospital Pharmacy And Its Organization -Ravinandan A P
Ravinandan A P1.6K vues
Essential Documents of Clinical Trials_2 par heba rashed
Essential Documents of Clinical Trials_2Essential Documents of Clinical Trials_2
Essential Documents of Clinical Trials_2
heba rashed12.5K vues
protocol preparation par AJIT THORAT
protocol preparationprotocol preparation
protocol preparation
AJIT THORAT2.6K vues
Abc analysis of given list of medication par Rafi Bhat
Abc analysis of given list of medication Abc analysis of given list of medication
Abc analysis of given list of medication
Rafi Bhat4.9K vues

Similaire à OVERVIEW OF ANTIMICROBIAL STEWARDSHIP

Antimicrobial stewardship CME 04-03-19 par
Antimicrobial stewardship CME 04-03-19Antimicrobial stewardship CME 04-03-19
Antimicrobial stewardship CME 04-03-19Tahseen Siddiqui
800 vues32 diapositives
Antimicrobial stewardship par
Antimicrobial stewardshipAntimicrobial stewardship
Antimicrobial stewardshipDr. Sohini Banerjee
225 vues22 diapositives
Antimicrobial stewardship.pptx par
Antimicrobial stewardship.pptxAntimicrobial stewardship.pptx
Antimicrobial stewardship.pptxJosephMalinda1
10 vues25 diapositives
Antimicrobial Stewardship par
Antimicrobial StewardshipAntimicrobial Stewardship
Antimicrobial StewardshipSantoshkumar Biradar
2.8K vues41 diapositives
Antimicrobial Stewardship par
Antimicrobial StewardshipAntimicrobial Stewardship
Antimicrobial StewardshipFatmaAtef10
200 vues66 diapositives
Infection Control and Antibiotic resistance par
Infection Control and Antibiotic resistanceInfection Control and Antibiotic resistance
Infection Control and Antibiotic resistanceMoustapha Ramadan
3.8K vues30 diapositives

Similaire à OVERVIEW OF ANTIMICROBIAL STEWARDSHIP(20)

Antimicrobial Stewardship par FatmaAtef10
Antimicrobial StewardshipAntimicrobial Stewardship
Antimicrobial Stewardship
FatmaAtef10200 vues
Infection Control and Antibiotic resistance par Moustapha Ramadan
Infection Control and Antibiotic resistanceInfection Control and Antibiotic resistance
Infection Control and Antibiotic resistance
Moustapha Ramadan3.8K vues
Antimicrobial Stewardship_Dr Chinmoy Sahu.pptx par Chinmoy Sahu
Antimicrobial Stewardship_Dr Chinmoy Sahu.pptxAntimicrobial Stewardship_Dr Chinmoy Sahu.pptx
Antimicrobial Stewardship_Dr Chinmoy Sahu.pptx
Chinmoy Sahu23 vues
Guidelines for rational use of antibiotics in surgical prophylaxis par DrLakshmiGayathripha
Guidelines for rational use of antibiotics in surgical prophylaxisGuidelines for rational use of antibiotics in surgical prophylaxis
Guidelines for rational use of antibiotics in surgical prophylaxis
guidelinesforantibiotics-200827064818.pdf par SridharA50
guidelinesforantibiotics-200827064818.pdfguidelinesforantibiotics-200827064818.pdf
guidelinesforantibiotics-200827064818.pdf
SridharA5011 vues
Who antibiotic policy iihmr jaipur par Ashish Gupta
Who antibiotic policy iihmr jaipurWho antibiotic policy iihmr jaipur
Who antibiotic policy iihmr jaipur
Ashish Gupta386 vues
4. Evolving Roles of Pharmacists in AMS by Dr. Mediadora Saniel.pdf par MarkAnthonyEllana1
4. Evolving Roles of Pharmacists in AMS by Dr. Mediadora Saniel.pdf4. Evolving Roles of Pharmacists in AMS by Dr. Mediadora Saniel.pdf
4. Evolving Roles of Pharmacists in AMS by Dr. Mediadora Saniel.pdf

Plus de TanveerRehman4

Validity & reliability of screening & diagnostic tests par
Validity & reliability of screening & diagnostic testsValidity & reliability of screening & diagnostic tests
Validity & reliability of screening & diagnostic testsTanveerRehman4
1.3K vues40 diapositives
MCH Care Indicators par
MCH Care IndicatorsMCH Care Indicators
MCH Care IndicatorsTanveerRehman4
15.6K vues27 diapositives
Indicators_demographic & fertility_practical class par
Indicators_demographic & fertility_practical classIndicators_demographic & fertility_practical class
Indicators_demographic & fertility_practical classTanveerRehman4
289 vues27 diapositives
Disease prevention strategies: Primary par
Disease prevention strategies: PrimaryDisease prevention strategies: Primary
Disease prevention strategies: PrimaryTanveerRehman4
831 vues17 diapositives
Approach to Neck and Back Pain par
Approach to Neck and Back PainApproach to Neck and Back Pain
Approach to Neck and Back PainTanveerRehman4
262 vues22 diapositives
District level bodies par
District level bodiesDistrict level bodies
District level bodiesTanveerRehman4
497 vues14 diapositives

Plus de TanveerRehman4(20)

Validity & reliability of screening & diagnostic tests par TanveerRehman4
Validity & reliability of screening & diagnostic testsValidity & reliability of screening & diagnostic tests
Validity & reliability of screening & diagnostic tests
TanveerRehman41.3K vues
Indicators_demographic & fertility_practical class par TanveerRehman4
Indicators_demographic & fertility_practical classIndicators_demographic & fertility_practical class
Indicators_demographic & fertility_practical class
TanveerRehman4289 vues
Disease prevention strategies: Primary par TanveerRehman4
Disease prevention strategies: PrimaryDisease prevention strategies: Primary
Disease prevention strategies: Primary
TanveerRehman4831 vues
Healthcare delivery - State level par TanveerRehman4
Healthcare delivery - State levelHealthcare delivery - State level
Healthcare delivery - State level
TanveerRehman41.3K vues
Developing counter strategy for Information warfare in Health Sector – siftin... par TanveerRehman4
Developing counter strategy for Information warfare in Health Sector – siftin...Developing counter strategy for Information warfare in Health Sector – siftin...
Developing counter strategy for Information warfare in Health Sector – siftin...
TanveerRehman423 vues
STATA - Basics of Analysis & Commands par TanveerRehman4
STATA - Basics of Analysis & CommandsSTATA - Basics of Analysis & Commands
STATA - Basics of Analysis & Commands
TanveerRehman4220 vues

Dernier

Relationships Between Service Providers and Families par
Relationships Between Service Providers and FamiliesRelationships Between Service Providers and Families
Relationships Between Service Providers and FamiliesOlaf Kraus de Camargo
93 vues22 diapositives
PCD Pharma Franchise In Chandigarh | Saphnix Lifesciences par
PCD Pharma Franchise In Chandigarh | Saphnix LifesciencesPCD Pharma Franchise In Chandigarh | Saphnix Lifesciences
PCD Pharma Franchise In Chandigarh | Saphnix LifesciencesSaphnix Lifesciences
8 vues7 diapositives
Basic Life support (BLS) workshop presentation. par
Basic Life support (BLS) workshop presentation.Basic Life support (BLS) workshop presentation.
Basic Life support (BLS) workshop presentation.Dr Sanket Nandekar
33 vues39 diapositives
melani glossophobia.pdf par
melani glossophobia.pdfmelani glossophobia.pdf
melani glossophobia.pdfPaygeon
9 vues1 diapositive
Depression PPT template par
Depression PPT templateDepression PPT template
Depression PPT templateEmanMegahed6
19 vues36 diapositives
Peptic ulcer.pdf par
Peptic ulcer.pdfPeptic ulcer.pdf
Peptic ulcer.pdfUVAS
7 vues64 diapositives

Dernier(20)

melani glossophobia.pdf par Paygeon
melani glossophobia.pdfmelani glossophobia.pdf
melani glossophobia.pdf
Paygeon9 vues
Peptic ulcer.pdf par UVAS
Peptic ulcer.pdfPeptic ulcer.pdf
Peptic ulcer.pdf
UVAS7 vues
sales forecasting (Pharma) par sristi51
sales forecasting (Pharma)sales forecasting (Pharma)
sales forecasting (Pharma)
sristi518 vues
BUKTI SOSIALISASI KODE ETIK DAN PERATURAN INTERNAL.docx 4,2,C.docx par InkhaRina
BUKTI SOSIALISASI KODE ETIK DAN PERATURAN INTERNAL.docx 4,2,C.docxBUKTI SOSIALISASI KODE ETIK DAN PERATURAN INTERNAL.docx 4,2,C.docx
BUKTI SOSIALISASI KODE ETIK DAN PERATURAN INTERNAL.docx 4,2,C.docx
InkhaRina32 vues
Top PCD Pharma Franchise Companies in India | Saphnix Lifesciences par Saphnix Lifesciences
Top PCD Pharma Franchise Companies in India | Saphnix LifesciencesTop PCD Pharma Franchise Companies in India | Saphnix Lifesciences
Top PCD Pharma Franchise Companies in India | Saphnix Lifesciences
MEDICAL RESEARCH.pptx par rishi2789
MEDICAL RESEARCH.pptxMEDICAL RESEARCH.pptx
MEDICAL RESEARCH.pptx
rishi278948 vues
LMLR 2023 Back and Joint Pain at 50 par Allan Corpuz
LMLR 2023 Back and Joint Pain at 50LMLR 2023 Back and Joint Pain at 50
LMLR 2023 Back and Joint Pain at 50
Allan Corpuz324 vues
Pharma Franchise For Critical Care Medicine | Saphnix Lifesciences par Saphnix Lifesciences
Pharma Franchise For Critical Care Medicine | Saphnix LifesciencesPharma Franchise For Critical Care Medicine | Saphnix Lifesciences
Pharma Franchise For Critical Care Medicine | Saphnix Lifesciences
Taking Action to Improve the Patient Journey With Transthyretin Amyloidosis (... par PeerVoice
Taking Action to Improve the Patient Journey With Transthyretin Amyloidosis (...Taking Action to Improve the Patient Journey With Transthyretin Amyloidosis (...
Taking Action to Improve the Patient Journey With Transthyretin Amyloidosis (...
PeerVoice7 vues

OVERVIEW OF ANTIMICROBIAL STEWARDSHIP

  • 1. OVERVIEW OF ANTIMICROBIAL STEWARDSHIP DR TANVEER REHMAN SCIENTIST – B (MEDICAL) PUBLIC HEALTH DIVISION
  • 2. 25/09/2023 AMS Dr Tanveer Rehman RMRCBB 2
  • 3. Background • Global Action Plan on Antimicrobial Resistance (AMR) • Overuse and misuse of antimicrobials as a main driver for development of AMR • Optimize the use of antimicrobial medicines in human and animal health • Practical guidance on how to implement antimicrobial stewardship (AMS) programmes in the human health sector at health-care facility • Improve patient outcomes, reduce AMR and health-care-associated infections, and save health-care costs amongst others 25/09/2023 AMS Dr Tanveer Rehman RMRCBB 3
  • 4. Antimicrobial stewardship • Careful and responsible management of something entrusted to one’s care • Applied in the health-care setting as a tool for optimizing antimicrobial use • One of three “pillars” of an integrated approach to health system strengthening • Infection prevention and control (IPC) and medicine and patient safety • WHO essential medicines list (EML) AWaRe classification • Promotes equitable and quality health care towards the goal of achieving universal health coverage (UHC) 25/09/2023 AMS Dr Tanveer Rehman RMRCBB 4
  • 5. ‘Access’ Group – WHO ‘AWaRe’ 25/09/2023 AMS Dr Tanveer Rehman RMRCBB 5
  • 6. ‘WAtch’ Group – WHO ‘AWaRe’ 25/09/2023 AMS Dr Tanveer Rehman RMRCBB 6
  • 7. ‘REserve’ Group – WHO ‘AWaRe’ 25/09/2023 AMS Dr Tanveer Rehman RMRCBB 7
  • 8. 25/09/2023 AMS Dr Tanveer Rehman RMRCBB 8
  • 9. Aim of AMS • Optimize the use of antibiotics • Promote behaviour change in antibiotic prescribing and dispensing practices • Improve quality of care and patient outcomes • Save on unnecessary health-care costs • Reduce further emergence, selection and spread of AMR • Prolong the lifespan of existing antibiotics • Build the best-practices capacity of health-care professionals 25/09/2023 AMS Dr Tanveer Rehman RMRCBB 9
  • 10. 25/09/2023 AMS Dr Tanveer Rehman RMRCBB 10
  • 11. 25/09/2023 AMS Dr Tanveer Rehman RMRCBB 11
  • 12. Antimicrobial prescribing facts • 30% of all hospitalised in-patient at any given time receive antibiotics • About 50% of antimicrobial use has been found to be inappropriate • Up to 30% of all surgical prophylaxis is inappropriate • URTI – reason for the 75% of the antibiotic prescriptions each year; in most cases of URTIs, antibiotic confers little or no benefit • 10-30% of antimicrobial cost can be saved by AMS • Globally, dentists were reported to prescribe up to 11.3 % of all antibiotics. 25/09/2023 AMS Dr Tanveer Rehman RMRCBB 12
  • 13. 25/09/2023 AMS Dr Tanveer Rehman RMRCBB 13
  • 14. Prospective (real-time) audit with feedback • Prospective audit with feedback (e.g. on ward rounds) involves the assessment of antibiotic therapy by AMS team, who make recommendations to prescribers in real time when therapy is considered suboptimal. • It may be performed alongside clinical personnel on ward rounds, providing oral recommendations for changes in antibiotic treatment in real time. • Alternatively, AMS team may perform ward rounds on their own, providing written recommendations for changes in antibiotic treatment 25/09/2023 AMS Dr Tanveer Rehman RMRCBB 14
  • 15. Formulary restriction/preauthorization • Use of restricted antibiotics may be limited to certain indications, prescribers, services, patient populations or a combination of these. • Selection of restricted antibiotics is done by facility authorities, the AMS team and heads of units based on spectrum, cost or toxicities. • Antibiotics are restricted before use; ensures expert approval before initiation • Practical approach that allows attending physician to use the drug pending approval by physician or AMS team after +/− 48 hours 25/09/2023 AMS Dr Tanveer Rehman RMRCBB 15
  • 16. Didactic education • Formal or informal teaching to engage prescribers in improving antibiotic prescribing, dispensing and administration practices • Clinical case discussions, classes, reminders, conference presentations, student and house staff teaching sessions, provision of written guidelines, informational pamphlets, posters or e-mail alert – STG/ updates • Education alone, without incorporation of active intervention is only marginally effective 25/09/2023 AMS Dr Tanveer Rehman RMRCBB 16
  • 17. Streamlining/de-escalation • All clinicians should perform a review of antibiotics 48 hours after prescription • When microbiological results become available, antibiotic treatment should be streamlined accordingly: choose the most active antibiotic(s) with least toxicity, narrowest spectrum and lowest cost • De-escalation is safe for sepsis and septic shock, and is associated with decreased mortality 25/09/2023 AMS Dr Tanveer Rehman RMRCBB 17
  • 18. 25/09/2023 AMS Dr Tanveer Rehman RMRCBB 18
  • 19. Outcome measures • Outcome measures/indicators related to antimicrobial use DDD or DOTS per 100(0) patient-days: Defined Daily Dose of an agent from pharmacy dispensing or health-care facility purchasing data or Days of Therapy from nursing chart administrative data (paper) in a period of time • Outcome measures/ indicators related to patients and microbiology In-hospital mortality, Length of stay, Readmission within 30 days after discharge Clostridium difficile: Number of health-care-associated C. difficile infections 25/09/2023 AMS Dr Tanveer Rehman RMRCBB 19
  • 20. Common areas for improving antibiotic prescribing • Overprescribing: when not needed, e.g. fever without evidence of infection, viral infections, malaria, asymptomatic urinary tract colonization • Overly broad spectrum: More broad-spectrum antibiotics (WATCH and RESERVE) are prescribed than are necessary (e.g. surgical prophylaxis) • Unnecessary combination therapy, including certain FDC: Multiple antibiotics are used, particularly with overlapping spectra and in combinations that have not been shown to improve clinical outcomes. 25/09/2023 AMS Dr Tanveer Rehman RMRCBB 20
  • 21. Common areas for improving antibiotic prescribing • Wrong antibiotic choice: Wrong antibiotic(s) are prescribed for particular indications/infections. • Wrong dose: Over- or under dosing • Wrong dose interval: Antibiotics are prescribed with the wrong dose interval (too much time between doses). • Wrong route: Antibiotics are prescribed by the wrong route (e.g. IV instead of oral). 25/09/2023 AMS Dr Tanveer Rehman RMRCBB 21
  • 22. What can the individual physicians do • Obtain appropriate cultures before starting antibiotic • Review antibiotic use after 48 – 72 hours : does it need to be continued? • Stop antibiotic in patient with alternative non-infectious diagnosis • Optimize dosing and duration of antibiotic therapy • Avoid unnecessary use, especially in viral upper respiratory tract infections 25/09/2023 AMS Dr Tanveer Rehman RMRCBB 22
  • 23. Health-care facility AMS team • Implements day-to-day AMS activities like conducting regular ward rounds • Undertakes audits or PPSs to assess the appropriateness of antibiotic prescription • Monitors, analyses and interprets the quantity and types of antibiotic use at the unit and/or facility-wide level • Monitors antibiotic susceptibility and resistance rates for a range of key indicator bacteria at the facility-wide level or uses the data from existing groups • Facilitates education and training on AMS in the facility. 25/09/2023 AMS Dr Tanveer Rehman RMRCBB 23
  • 24. Health-care facility AMS team Option 1: >2 : physician, a pharmacist, a nurse with expertise in infections or IPC, and in facilities with a microbiology laboratory, a microbiologist Option 2: a physician and a nurse or pharmacist, with access to expert advice Option 3: an AMS champion, e.g. a physician, nurse or pharmacist leading the stewardship programme, with access to expert advice (e.g. secondary or small facilities with limited resources). • Frequency of meetings: Weekly to two times a month 25/09/2023 AMS Dr Tanveer Rehman RMRCBB 24
  • 25. THANK YOU 25/09/2023 AMS Dr Tanveer Rehman RMRCBB 25 References 1. ICMR. Antimicrobial Stewardship Program Guideline 2. Antimicrobial stewardship programmes in health-care facilities in low-and middle-income countries: a WHO practical toolkit 3. Vijay S, Ramasubramanian V, Bansal N, Ohri VC, Walia K. Hospital-based antimicrobial stewardship, India. Bulletin of the World Health Organization. 2023